Workshop: Photo-switchable editing tools: Towards safe editing & in vivo gene therapy

Tuesday, March 19, 2024 at 11:00 AM to 12:00 PM · 1 hr. (Europe/London)
Supply Chain & Logistics [Track 4]
Panel Discussion
I-GENE project: In-Vivo Gene Editing By NanotransducErs
114
I-GENE or “In-Vivo Gene Editing By NanotransducErs” is a European funded project under the FET-OPEN scheme that focuses on overcoming current limitations of genome editing. The main issues of the current technologies are impaired in vivo delivery of the editing complexes, and high off target activity by the nucleases. I-GENE is applying Boolean Logic and Nanotransducers for efficient delivery of the technology and safer gene editing. If you are interested to learn more about the project and our future plans, please come to meet our team at the booth 114!

Registered attendees

John Bridgeman
John Bridgeman
Director of Cell Therapy ResearchInstil Bio
Kathryn Ivey
Kathryn Ivey
VP, Gene Therapy ResearchTenaya Therapeutics
Marina Tarunina
Marina Tarunina
Research DirectorPlasticell

Log in

See all the content and easy-to-use features by logging in or registering!